The limitations of our study included the lack of molecular-based analysis of the direct link between CCNDBP1 and EZH2 and of human HCC samples to enable application of the results to radiotherapy and chemotherapy resistance. Here, CCNDBP1 is linked to hepatocellular carcinoma.